Shanghai Kangdai Biopharmaceutical Technology

Shanghai Kangdai Biopharmaceutical Technology is a specialized biotechnology company headquartered in Shanghai, focusing on the discovery and development of therapeutic antibodies. The company utilizes advanced platforms such as the Beacon single-cell screening system and phage display technologies to accelerate the identification of high-affinity lead candidates. Kangdai's expertise extends to challenging targets, including G protein-coupled receptors (GPCRs) and multi-pass transmembrane proteins. By providing end-to-end services from antigen design to stable cell line construction, the company supports both its internal discovery efforts and external collaborations with biopharmaceutical partners. Their business model integrates contract research services with early-stage biologics innovation.